ASMB - BottomASMB has formed a double bottom along the lower trend line of a falling wedge that can be plotted
This may lead to a bullish breakout of the pattern, similar to the previous one on the first vertical line
Weekly chart
ASMB trade ideas
$ASMB Assembly Biosciences Ready for Reversal.
Hopefully you find the chart helpful in terms of Supports & Resistance etc.
we refrain from adding commentary on the chart as that is reserved for our members and we are very conscious of not giving financial or trading advice.
Thank you for taking time to consult our chart and we would really appreciate a like, follow or comment.
ASMB Technical Analysis 🧙Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ASMB Technical Analysis 🧙Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
If you want more trading ideas like this one,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Potential 200% playAnother play that will only pay the paytient ones. My entry would be TSI crossover on the weekly. This is a buy and forget situation I believe as this will take at the least several months to recover.
ASMB Bullish Signal UPDATEThis is just a simple update showing a long term bullish pattern that is supported by various indicators showing the most obvious its time to get our feet wet. Please DYOR If you want to see hit the like and subcribe botton.
ASMB long term Buy EntryThe stock has outperformed and what I currently see Technically is strong upwards movements.
DYOR and if u like please hit the like button and subscribe for more updates.
NASDAQ: ASMB / Assembly Biosciences IncHi.
This one turn from bottom to top.
I'll close it when it reaches the target.
If you want new shares, you know what to do.
Like and follow.
Thinking about how to catch up this big clear uptrend. what's yoThinking about how to catch up this big clear uptrend. what's your target about this?
I am interested in where will this go.
ASSEMBLY BIOSCIENCES SEARCHING FOR A REBOUNDAfter a long descend the prices are now supported by the the 200 weekly SMA.
It is possible to try a long from this level searching for a rebound.
ASMB Buypossible bullish bounce on support(with a bullish divergence on the daily) @ $36.56 and possible target @ $60.75.
Assembly Biosciences, Inc. Swing, Technical Set up Possible 14% NASDAQ:ASMB
Assembly Biosciences, Inc. Ticker ASMB showing a possible upside of ~14%
Moving Averages: ASMB recently crossed the 20 day ma on 1/11/2018 giving it a short term bullish outlook. Currently sitting at 6.21% above the 20ma, 11.93% above the 50ma and 58.38% above the 200ma.
MACD: MACD indicator showing a bullish signal with the signal line crossing above the moving average. The stocks past performance after showing this signal is a run of 53.7% from 11/6/2017 to 11/30/2018, and ~77.5% from 7/10/2018 to 10/9/2018.
RSI(14): Showing increasing momentum, going from ~45 to 62.47 since 1/8/2018, and is still not overbought.
Has been consolidating in the 48.05 to 41.80 range for almost two months now, has recently broken out of a trend line.
FIB Levels:
Supports :41.30
Resistance: 49.85 (ATH very influential), 58.50, 63.80
